เอกสารอ้างอิง
[1]. Brunsell SC. Contraception. In: South-Paul JE, Matheny SC, Lewis EL. eds. CURRENT Diagnosis & Treatment: Family Medicine, 5e. McGraw Hill; 2020. [cited 24 Nov. 2022]. Available from: https://accessmedicine.mhmedical.com/content.aspx?bookid=2934§ionid=247399247.
[2]. Family Planning NSW. Contraceptive Injection [Internet]. [cited 20 Nov. 2022]. Available from: https://www.fpnsw.org.au/factsheets/individuals/contraception/contraceptive-injection.
[3]. Medroxyprogesterone. In: AHFS Essentials online [database on the Internet]. Hudson (OH): Lexicomp, Inc.; 2022 [updated 28 Mar. 2022; cited 23 Nov. 2022]. Available from: https://online.lexi.com/lco/action/doc/retrieve/docid/essential_ashp/410375.
[4]. Medroxyprogesterone acetate injection [package insert]. Kalamazoo (MI): Pharmacia & Upjohn Pharmaceuticals; 2004.
[5]. Medroxyprogesterone acetate injection [package insert]. Parsippany (NJ): Teva Pharmaceuticals; 2022.
[6]. Li CI, Beaber EF, Tang MT, Porter PL, Daling JR, Malone KE. Effect of depo-medroxyprogesterone acetate on breast cancer risk among women 20 to 44 years of age. Cancer Res. 2012;72(8):2028-2035.
[7]. Skegg DC, Noonan EA, Paul C, Spears GF, Meirik O, Thomas DB. Depot medroxyprogesterone acetate and breast cancer. A pooled analysis of the World Health Organization and New Zealand studies. JAMA. 1995;273(10):799-804.
[8]. Nindrea RD, Aryandono T, Lazuardi L. Breast Cancer Risk From Modifiable and Non-Modifiable Risk Factors among Women in Southeast Asia: A Meta-Analysis. Asian Pac. J. Cancer Prev. 2017;18(12):3201-3206.
[9]. Barańska A, Błaszczuk A, Kanadys W, Malm M, Drop K, Polz-Dacewicz M. Oral Contraceptive Use and Breast Cancer Risk Assessment: A Systematic Review and Meta-Analysis of Case-Control Studies, 2009-2020. Cancers (Basel). 2021;13(22):5654.
[10]. Kanadys W, Barańska A, Malm M, et al. Use of Oral Contraceptives as a Potential Risk Factor for Breast Cancer: A Systematic Review and Meta-Analysis of Case-Control Studies Up to 2010. Int. J. Environ. Res. Public Health. 2021;18(9):4638.
[11]. Urban M, Banks E, Egger S, et al. Injectable and oral contraceptive use and cancers of the breast, cervix, ovary, and endometrium in black South African women: case-control study. PLoS Med. 2012;9(3):e1001182.
[12]. Poosari A, Promthet S, Kamsa-ard S, Suwanrungruang K, Longkul J, Wiangnon S. Hormonal contraceptive use and breast cancer in Thai women. J. Epidemiol. 2014;24(3):216-220.
[13]. Samson M, Porter N, Orekoya O, et al. Progestin and breast cancer risk: a systematic review. Breast Cancer Res. Treat. 2016;155(1):3-12.